MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Sessions
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Dopamine Transporter Imaging as Monitoring Biomarker in Parkinson’s Disease

    V. Dzialas, G. Bischof, K. Möllenhoff, A. Drzezga, T. van Eimeren (Cologne, Germany)

  • Dopamine transporter imaging to predict the risk of aspiration in patients with Parkinson’s disease

    J. Tanimura, T. Yamamoto, Y. Shigemoto, N. Sato, Y. Takahashi (Kodaira, Tokyo, Japan)

  • Dopaminergic Adverse Events With 24-hour Subcutaneous Infusion of ND0612

    S. Isaacson, O. Rascol, H. Sarva, R. Hauser, F. Stocchi, N. Lopes, L. Salin, J. Pereira, N. Giladi (Boca Raton, USA)

  • Dopaminergic alterations in patients with Alzheimer’s disease

    M. Azharuddin, M. Sharma (New Delhi, India)

  • Dopaminergic denervation and focal motor progression in early Parkinson’s Disease: A 5-year longitudinal study

    MA. Ruiz Yanzi, M. Matarazzo, JA. Pineda-Pardo, T. Jiménez-Castellanos, MHG. Monje, A. Sánchez-Ferro, R. Martínez-Fernández, C. Gasca-Salas, JA. Obeso (Madrid, Spain)

  • Dose-dependent alterations of lysosomal activity and alpha-synuclein level in peripheral blood monocyte-derived macrophages and SH-SY5Y neuroblastoma cell line by upon inhibition of mTOR kinase activity

    A. Bezrukova, K. Basharova, G. Baydakova, E. Zakharova, S. Pchelina, T. Usenko (Gatchina, Russian Federation)

  • DPPX Autoimmune Encephalitis Associated with Severe Multifocal Dystonia.

    E. Roddy, E. Gentry, P. Hedera, V. Holiday, D. Robertson (LOUISVILLE, USA)

  • Driving assessment in older patients with Parkinson’s in United Kingdom.

    M. Khwaja, T. Nanayakkara, G. Pun, R. Miah, N. Butt, A. Chatterjee (Reading, United Kingdom)

  • Drug-Induced Parkinsonism and Tardive Dyskinesia in Rats Chronically Treated with Haloperidol

    H. Hikichi, H. Nishijima, F. Mori, I. Kinoshita, C. Murakami, M. Tomiyama (Hirosaki, Japan)

  • Drug-induced tremors: A scoping review to assess knowledge gaps, controversies, and future directions

    S. Desai, D. Desai (Anand, India)

  • « Previous Page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley